University Campus Bio-Medico of Rome, Department of Orthopedics and Traumatology.
University Campus Bio-Medico of Rome, Physical and Rehabilitation Medicine.
J Biol Regul Homeost Agents. 2017 Dec 27;31(4 Suppl 2):23-32.
Adhesive capsulitis (AC) is a common pathological condition of the shoulder characterized by painful restriction of range of motion (ROM) of the glenohumeral joint. Currently, no consensus has been reached regarding the best treatment. Hyaluronic acid (HA) injection is a safe procedure that can result in significant improvement in active and passive ROM, alleviating pain and improving shoulder function. We systematically reviewed current literature in order to evaluate the best evidence about the effectiveness of intra-articular HA injection for the treatment of primary AC. We searched Medline, CINAHL, Embase, Google Scholar and Cochrane Library. We selected studies comparing clinical outcomes of patients treated with HA in association or not with conventional therapy. Seven studies were evaluated: 2 uncontrolled randomized studies and 5 prospective randomized clinical trials with level of evidence I. Clinical outcome measures used included, among other, ROM, Visual Analogic Scale (VAS) pain scores, Constant score, Activity of daily living, Shoulder Pain and Disability Index (SPADI), American Shoulder and Elbow Surgeons (ASES) and Japanese Orthopedic Association Score (JOA score). Improvement was noted in terms of ROM, constant scores and pain in patients affected by AC treated with intra-articular HA injections. When compared with cortisone intra-articular injection, HA has equivalent clinical outcomes and ROM. The heterogeneity of treatments used in the studies reviewed, makes it difficult to draw a definite conclusion on the subject. HA injections do not seem to determine the final outcomes directly compared with conventional treatments. However, they could play an important role for early mobilization in the initial stages, during which, due to pain and inflammation, the patient keeps the shoulder immobilized for a long time, determining the direct cause of AC. Numerous variables, including use of lidocaine, different HA and AC stages, could influence the results and deserve to be accounted for in future investigations.
粘连性肩关节囊炎(adhesive capsulitis,AC)是一种常见的肩关节病理性疾病,其特征为肩关节活动度(range of motion,ROM)受限伴疼痛。目前,对于最佳治疗方案尚未达成共识。透明质酸(hyaluronic acid,HA)注射是一种安全的治疗方法,可显著改善主动和被动 ROM,减轻疼痛并改善肩关节功能。我们系统地回顾了当前的文献,以评估关节内 HA 注射治疗原发性 AC 的最佳证据。我们检索了 Medline、CINAHL、Embase、Google Scholar 和 Cochrane Library。我们选择了比较 HA 联合或不联合常规治疗的患者临床结局的研究。评估了 7 项研究:2 项非对照随机研究和 5 项 I 级前瞻性随机临床试验。使用的临床结局测量指标包括 ROM、视觉模拟评分(visual analogic scale,VAS)疼痛评分、Constant 评分、日常生活活动能力、肩关节疼痛和残疾指数(shoulder pain and disability index,SPADI)、美国肩肘外科医师协会(American Shoulder and Elbow Surgeons,ASES)评分和日本矫形协会评分(Japanese Orthopedic Association score,JOA score)。接受关节内 HA 注射治疗的 AC 患者的 ROM、Constant 评分和疼痛均有改善。与关节内皮质类固醇注射相比,HA 具有等效的临床结局和 ROM。由于研究中使用的治疗方法存在异质性,因此难以对该主题得出明确结论。与常规治疗相比,HA 注射似乎不能直接决定最终结局。然而,它们可能在初始阶段的早期活动中发挥重要作用,在此期间,由于疼痛和炎症,患者长时间使肩部保持固定,这是导致 AC 的直接原因。许多变量,包括使用利多卡因、不同的 HA 和 AC 阶段,可能会影响结果,值得在未来的研究中考虑。